November 2, 2022 by Chain Drug Review
CVS, Karen Lynch, Opioid, third quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health easily beat analysts’ sales and earnings estimates for the third quarter and again raised its full year guidance. The company reported adjusted earnings per share $2.09 on revenue of $81.16 billion, which climbed 10% from a year earlier. Wall Street had expected adjusted EPS of $1.99 on revenue of $76.75
August 25, 2020 by Chain Drug Review
DrFirst, Opioid
Leading Headlines, Pharmacy
ROCKVILLE, Md. – In the midst of the war against opioid addiction, most Americans don’t recognize if they are prescribed an opioid, according to a new survey by health technology pioneer DrFirst. The survey of more than 1,000 U.S. adults—which looked at Americans’ opinions, knowledge, and usage of opioid-containing medications—discovered that almost a quarter of
January 3, 2020 by Chain Drug Review
Auburn University's Harrison School of Pharmacy, Center for Opioid Research, Dr. Richard Hansen, Education and Outreach, Opioid, or COACH
Leading Headlines, Pharmacy
AUBURN, Ala. — In an effort to combat a public health crisis that affects those in Alabama and throughout the country, Auburn University’s Harrison School of Pharmacy has established the Center for Opioid Research, Education and Outreach, or COACH. The center unifies a variety of existing programs and research going on at the Harrison School of
October 23, 2018 by Stephanie Kennan
Department of Health and Human Services, Medicaid, Opioid
Issue 10-22-2018
Routine monitoring of medication adherence is one of the Medicaid programs that must be included under a new law passed by Congress in response to the opioid epidemic. The recently passed opioid legislation makes improvements in treatment capacity for Medicaid patients. However, the legislation has significance for the pharmacy industry because it directs the Department
April 26, 2018 by Chain Drug Review
Amerisource Bergen, Opioid
Pharmacy
VALLEY FORGE, Pa. — The AmerisourceBergen Foundation has launched a new grant program broadening its efforts to curb opioid abuse. The Opioid Resource Grant Program builds off of continuous and ongoing efforts through the foundation to support and advance ideas from innovative nonprofit, grant-funded organizations, in an effort to redefine best practices across the country
April 18, 2018 by gwalden
DEA, drug distributors, HDA, John Gray, Opioid, prescription drug abuse
Pharmacy
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and CEO John Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation
April 17, 2018 by Chain Drug Review
NACDS, Opioid, Steve Anderson
Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores has endorsed S. 2645, the Access to Increased Drug Disposal Act of 2018, which is consistent with the spirit of NACDS’ policy recommendations to help address the opioid abuse epidemic. Sen. Joni Ernst (R., Iowa) introduced the legislation, with the bipartisan original co-sponsorship of Sen. Chuck
June 6, 2016 by John Schultz
CVS Health, Dr. Steven Stack, Opioid, Sen. Dick Durban, Walgreens
2016, Issue 06-06-2016, Issues, News
NEW YORK — Opioid prescriptions have dropped for the first time in two decades, but dealing with the threat of misuse of the powerful painkillers remains a challenge for retail pharmacies and the health care system. Industry leaders are expressing hope that the decline in such prescriptions last year, preceded by dips in 2014 and